• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital.

作者信息

Sato T, Hanaoka R, Ohshima M, Miwa Y, Okazaki Y, Yajima N, Ishizashi H, Matsumoto M, Fujimura Y, Inokuma S

出版信息

Clin Exp Rheumatol. 2006 Jul-Aug;24(4):454-5.

PMID:16956441
Abstract
摘要

相似文献

1
Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital.结缔组织病继发血栓性血小板减少性紫癜患者中ADAMTS13活性及其抑制剂的分析：单中心观察
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):454-5.
2
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.ADAMTS13和抗ADAMTS13抗体作为获得性血栓性血小板减少性紫癜缓解期复发的标志物。
Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26.
3
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.获得性血栓性血小板减少性紫癜患者对血浆置换治疗反应不佳与ADAMTS13抑制剂增强有关：ADAMTS13抑制剂复合物的可视化及其从血浆中的蛋白水解清除。
Transfusion. 2015 Oct;55(10):2321-30. doi: 10.1111/trf.13182. Epub 2015 Jun 8.
4
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.急性血栓性血小板减少性紫癜中针对血管性血友病因子裂解蛋白酶的抗体。
N Engl J Med. 1998 Nov 26;339(22):1585-94. doi: 10.1056/NEJM199811263392203.
5
[ADAMTS13 and thrombotic thrombocytopenic purpura retrospective study at the hospital of Le Mans].[勒芒医院关于ADAMTS13与血栓性血小板减少性紫癜的回顾性研究]
Ann Biol Clin (Paris). 2014 May-Jun;72(3):321-30. doi: 10.1684/abc.2014.0951.
6
Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.结缔组织病和抗磷脂综合征患者的血浆ADAMTS13、血管性血友病因子（VWF）及VWF前体肽谱
Clin Appl Thromb Hemost. 2017 Sep;23(6):622-630. doi: 10.1177/1076029615625832. Epub 2016 Jan 11.
7
Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13.免疫吸附治疗对血浆置换耐药的重症血栓性血小板减少性紫癜患者：ADAMTS13抑制剂的动力学
J Thromb Haemost. 2003 Jan;1(1):187-9. doi: 10.1046/j.1538-7836.2003.00004.x.
8
[Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].[血栓性血小板减少性紫癜——ADAMTS13活性的病理生理学及检测]
Rinsho Byori. 2015 Oct;63(10):1228-36.
9
Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.聚乙二醇化干扰素-α治疗复发性自身免疫性血栓性血小板减少性紫癜患者的慢性丙型肝炎
Transfus Med. 2013 Feb;23(1):66-68. doi: 10.1111/j.1365-3148.2012.01197.x. Epub 2012 Oct 29.
10
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.血栓性血小板减少性紫癜和溶血尿毒综合征中的血管性血友病因子裂解蛋白酶
N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202.

引用本文的文献

1
Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy.利妥昔单抗治疗结缔组织病相关血栓性血小板减少性紫癜/血栓性微血管病的疗效和安全性
Int J Rheum Dis. 2025 Jun;28(6):e70292. doi: 10.1111/1756-185X.70292.
2
Secondary immune-mediated thrombotic thrombocytopenic purpura in idiopathic inflammatory myopathy: a case-based review.特发性炎症性肌病继发免疫介导性血栓性血小板减少性紫癜：基于病例的综述。
Rheumatol Int. 2023 Mar;43(3):551-557. doi: 10.1007/s00296-022-05260-8. Epub 2022 Dec 28.
3
Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report.
系统性红斑狼疮起病时伴血栓性血小板减少性紫癜：一例报告
Front Pediatr. 2022 Aug 1;10:931669. doi: 10.3389/fped.2022.931669. eCollection 2022.
4
Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement.抗 PM/Scl 抗体阳性的系统性硬化症合并多器官受累。
Intern Med. 2021 Apr 1;60(7):1101-1107. doi: 10.2169/internalmedicine.5665-20. Epub 2020 Nov 2.
5
Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.血栓性血小板减少性紫癜合并髓过氧化物酶抗中性粒细胞胞浆自身抗体相关性血管炎的成功治疗。
NDT Plus. 2010 Jun;3(3):279-281. doi: 10.1093/ndtplus/sfq013. Epub 2010 Feb 28.